Globe Newswire10.05.20
FH Ortho Inc. a manufacturer of orthopedic implantable devices has announced the U.S. Food and Drug Administration clearance of its e-Ortho planning software that will further expand the Arrow Prime Shoulder Arthroplasty platform.
Jean-Marc Idier, president and CEO of FH Ortho, stated, “e-Ortho demonstrates our commitment to advancements in shoulder arthroplasty by providing our customers with increased value through a means of simplifying procedures to achieve our ultimate goal of improving outcomes for our patients.”
e-Ortho is a next-generation 3D planning software that provides shoulder replacement surgeons with a web-based platform to assist in preoperative surgical technique planning without the need for costly custom instruments that are required with other planning software systems.
Jean-Marc Idier, president and CEO of FH Ortho, stated, “e-Ortho demonstrates our commitment to advancements in shoulder arthroplasty by providing our customers with increased value through a means of simplifying procedures to achieve our ultimate goal of improving outcomes for our patients.”
e-Ortho is a next-generation 3D planning software that provides shoulder replacement surgeons with a web-based platform to assist in preoperative surgical technique planning without the need for costly custom instruments that are required with other planning software systems.